Patent Analysis For Medicines And Biotherapeutics In Trials To Treat COVID - 19

This report provides an analysis of patents covering medicines in trials to treat COVID -19. The aim of the report is to suport national patent offices and interested parties in developing countrie…

Designing Pro - Health Competition Policies In Developing Countries

Competition law and policy has become an important tool for countries to promote access to pharmaceuticals. How can countries design and enforce competition policies that are suitableto the particu…

The TRIPS Agreement Article 73 Security Exceptions And The COVID -19 Pandemic

The COVID -19 pandemic has caused Governments to contemplate measures to override patents and other intellectual property rights (IPRs) in order to facilitate production and distribution of vaccine…

Special Section 301 : US Interference with the Design and Implementation of N…

The continous application of Special Section 301 by the Office of the United States Trade Representative (USTR) undermines the rule of law as a fundamental principle of a multilateral system bases …

Guide for the Granting of Compulsory Licenses and Government Use of Pharmaceu…

Like other rights, patent rights are not absolute. There are situations in which their exercise can be limited to protect public interests. Such situations may arise, for instance, when access to n…

Second Medical Use Patents - Legal Treatment and Public Health Issues

This paper attempts to give an overview of the debate surrounding the patentability of new therapeutic uses for known active ingredients, both in developed and developing countries. After close scr…

MITIGATING THE REGULATORY CONSTRAINTS IMPOSED BY INTELLECTUAL PROPERTY RULES …

Edisi

February 2017

ISBN/ISSN

ISSN 1819 - 6926

Deskripsi Fisik

33 hlm

Judul Seri

Research Paper

No. Panggil

346.048 CAR m

ACCESS TO MEDICINES : EXPERIENCES WITH COMPULSORY LICENSES AND GOVERNMENT USE…

This South Centre research paper discusses first, the limitations of the current research and development (R&D) model and its implications for access to medicines. Second, it considers the tension …

Intellectual Property, Innovation and Access to Health Products for COVID-19 …

The rising incidence of COVID-19 will require all countries, particularly developing and least developed countries, to be able to procure and manufacture the products required for the diagnosis, pr…

INTELLECTUAL PROPERTY AND ACCESS TO MEDICINES : AN INTRODUCTION TO KEY ISSUES…

Intellectual property and patents in particular, have become one of the most debated issues on access to medicines, since the creation of the World Trade Organization (WTO) and the coming into forc…